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Inpatient and Outpatient Infection as a Trigger of Cardiovascular
Disease: The ARIC Study
Logan T. Cowan, PhD, MPH; Pamela L. Lutsey, PhD, MPH; James S. Pankow, PhD, MPH; Kunihiro Matsushita, MD, PhD;
Junichi Ishigami, MD, MPH; Kamakshi Lakshminarayan, MD, PhD

Background-—Acute infections are known cardiovascular disease (CVD) triggers, but little is known regarding how CVD risk varies
following inpatient versus outpatient infections. We hypothesized that in- and outpatient infections are associated with CVD risk
and that the association is stronger for inpatient infections.
Methods and Results-—Coronary heart disease (CHD) and ischemic stroke cases were identiﬁed and adjudicated in the ARIC
(Atherosclerosis Risk in Communities Study). Hospital discharge diagnosis codes and Medicare claims data were used to identify
infections diagnosed in in- and outpatient settings. A case-crossover design and conditional logistic regression were used to
compare in- and outpatient infections among CHD and ischemic stroke cases (14, 30, 42, and 90 days before the event) with
corresponding control periods 1 and 2 years previously. A total of 1312 incident CHD cases and 727 incident stroke cases were
analyzed. Inpatient infections (14-day odds ratio [OR]=12.83 [5.74, 28.68], 30-day OR=8.39 [4.92, 14.31], 42-day OR=6.24 [4.02,
9.67], and 90-day OR=4.48 [3.18, 6.33]) and outpatient infections (14-day OR=3.29 [2.50, 4.32], 30-day OR=2.69 [2.14, 3.37], 42day OR=2.45 [1.97, 3.05], and 90-day OR=1.99 [1.64, 2.42]) were more common in all CHD case periods compared with control
periods and inpatient infection was a stronger CHD trigger for all time periods (P<0.05). Inpatient infection was also a stronger
stroke trigger with the difference borderline statistically signiﬁcant (P<0.10) for the 42- and 90-day time periods.
Conclusions-—In- and outpatient infections are associated with CVD risk. Patients with an inpatient infection may be at particularly
elevated CVD risk and should be considered potential candidates for CVD prophylaxis. ( J Am Heart Assoc. 2018;7:e009683.
DOI: 10.1161/JAHA.118.009683.)
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P

opulation-based cohort studies have identiﬁed many
chronic risk factors for cardiovascular disease (CVD) that
are both modiﬁable, such as high blood pressure, elevated
serum cholesterol, and smoking, and non-modiﬁable, such
as male sex, nonwhite race, family history, and greater
age.1,2 Acute risk factors—or triggers—of CVD are less
studied. Identifying and understanding CVD triggers offer
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potential new strategies for CVD prevention during vulnerable periods.
Previous research has provided evidence that acute
infections triggers CVD events, including myocardial
infarction3–8 and stroke.3,9,10 Although the results of these
studies are informative, most previous studies only included
hospitalized infections as their exposure of interest whereas
studies that have considered the impact of outpatient
infections on CVD risk are scarce. Furthermore, the magnitude and duration of increased cardiovascular risk has varied
greatly between studies and remains under debate.
We expanded upon our previous work linking inpatient
infection with stroke9 by using longitudinal data from the ARIC
(Atherosclerosis Risk in Communities) study, which have been
linked to Centers for Medicare and Medicaid Services data, to
examine the relationship between infections diagnosed in
both in- and outpatient settings and coronary heart disease
(CHD) and ischemic stroke. We hypothesized that infections
among both in- and outpatients are independently associated
with risk of CHD and ischemic stroke and that the association
will be stronger among infections diagnosed in inpatient
settings compared with infections diagnosed in outpatient
Journal of the American Heart Association
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What Is New?
• Patients with infection have higher odds of coronary heart
disease and ischemic stroke up to 90 days after infection.
• Inpatient infection appears to be a stronger coronary heart
disease and ischemic stroke trigger compared with outpatient infection.

What Are the Clinical Implications?
• Patients with an inpatient infection may be potential
candidates for cardiovascular disease prophylaxis.

settings given that they are likely more severe. We further
hypothesized that the infection-CVD association is graded
such that the association is strongest immediately following
infection and decreases as the time after infection increases.

Methods
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The data, analytical methods, and study materials will not be
made available to other researchers for purposes of reproducing the results or replicating the procedure. However, the
ARIC study data are publicly available through the database of
Genotypes and Phenotypes and the National Heart, Lung, and
Blood Institute Biological Specimen and Data Repository
Information Coordinating Center.11

Study Design
The ARIC study is a multicenter, population-based, prospective cohort study designed to investigate the etiology and
natural history of atherosclerosis in middle-aged Americans.12
At baseline in 1987–1989 (visit 1), 15 792 mostly white and
black men and women were selected from 4 US communities:
Forsyth County, North Carolina; Jackson, Mississippi; suburbs

of Minneapolis, Minnesota; and Washington County,
Maryland.12 Subsequent exams took place during 1990–
1992 (visit 2), 1993–1995 (visit 3), 1996–1998 (visit 4),
2011–2013 (visit 5), and 2016–2017 (visit 6). Institutional
review board approval was obtained at each participating
ARIC site, and informed consent was obtained from each ARIC
study participant.
We used a case-crossover study design in which ARIC
participants with incident CHD or ischemic stroke served as
their own controls. Occurrence of infection immediately
preceding CVD events was compared with preceding time
intervals 1 and 2 years before the CVD event. The crossover
study design is summarized in Figure 1. Additionally, we
performed sensitivity analyses using nonoverlapping time
intervals and using only 1 annual control period.
All ARIC participants with incident CHD or ischemic
stroke events during follow-up were included. CHD and
stroke analyses were done independently, thus study
participants with both incident CHD and ischemic stroke
events were included in both analyses. Within each analysis,
participant cases were independent because only incident
cases were included whereas recurrent events were not
considered. CVD events were identiﬁed using information
collected at each exam, annual telephone questionnaires,
and hospitalizations. Hospitalizations were identiﬁed by
surveillance of local hospital discharge lists for cohort
members. Information obtained at study visits, during
telephone questionnaires, and through review and abstraction of hospital and death records were used to adjudicate
CVD outcomes and identify inpatient infections.13 Additionally, Centers for Medicare and Medicaid Services claims data
were used to identify both in- and outpatient infections in
ARIC study participants. Centers for Medicare and Medicaid
Services claims data for in- and outpatient services were
available since 1991. We excluded individuals who were
aged <67 years at the time of their CVD event because they
were not Medicare eligible for both the case and control
periods. We also excluded participants whose CVD events

Figure 1. Case-crossover study design used to study infection as a cardiovascular disease trigger, the ARIC (Atherosclerosis
Risk in Communities) Study. CHD indicates coronary heart disease.
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Infection Ascertainment
The exposure of interest was infection determined using
International Classiﬁcation of Diseases, Ninth Revision (ICD-9)
codes. Inpatient hospitalization codes and outpatient visit
codes were used to identify infections. Infections diagnosed in
inpatient settings are referred to as inpatient infections
whereas infections diagnosed in outpatient settings are
termed outpatient infections throughout the article. Table 1
contains the infection types and corresponding ICD-9 codes
that were included in our exposure of interest. In the main
analysis, codes in any position were counted. We also
Table 1. Infection Type and Corresponding ICD-9 Codes
Included in the Exposure of Interest
Infection

ICD-9 Codes

Other infectious diseases

001 to 139

Thymus gland infection

254.1

Downloaded from http://ahajournals.org by on May 28, 2021

Nervous system infections

320 to 326, 331.81

Eye infections

372 to 372.39, 373.0 to 373.2

Ear infections

382 to 382.4, 383, 386.33,
386.35, 388.60

Circulatory infections

390 to 393, 421 to 421.1, 422.0,
422.91 to 422.93

Respiratory infections

460 to 466, 472 to 474.0, 475 to
476.1, 478.21 to 478.24, 478.29,
480 to 490, 491.1, 494, 510 to
511, 513.0, 518.6, 519.01

Digestive infections

522.5, 522.7, 527.3, 528.3, 540 to
542, 566 to 567.9, 569.5, 572 to
572.1, 573.1 to 573.3, 575 to
575.12

Urinary tract infections

590 to 590.9, 595 to 595.4, 597 to
597.89, 598.0, 599.0

Male genital infections

601 to 601.9, 604 to 604.9, 607.1,
607.2, 608.0, 608.4

Breast infections

611.0

Female pelvic infections

614 to 616.1, 616.3 to 616.4, 616.8

Puerperal infections

670

Skin and subcutaneous
infections

680 to 686.9, 706.0

Musculoskeletal infections

711 to 711.9, 730 to 730.3,
730.8 to 730.9,

Blood infections

790.7 to 790.8

Healthcare-acquired infections

996.60 to 996.69, 997.62, 998.5,
999.3

ICD-9 indicates International Classiﬁcation of Diseases, Ninth Revision.
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performed a sensitivity analysis in which only infection
diagnosed primarily (ﬁrst position) were counted. Given that
some infection types may be associated with CVD through
direct mechanisms, we also performed a sensitivity analysis
only using the most common infection types (urinary tract
infections, pneumonia, cellulitis, and blood infections).
Table S1 contains the infection types and corresponding
ICD-9 codes that were included in the exposure of interest for
this sensitivity analysis.

Cardiovascular Events
The outcomes of interest were CHD and ischemic stroke. The
methods used for outcome ascertainment included:
(1) participants were contacted annually by phone and
interviewed about interim hospitalizations; (2) local hospitals
provided lists of hospital discharges with cardiovascular
diagnoses that were reviewed to identify cohort hospitalizations; and (3) health department death certiﬁcate ﬁles were
regularly surveyed. All discharge codes for cohort hospitalizations and listed causes of death from death certiﬁcates
were recorded. CVD events were classiﬁed by a combination
of computer algorithm and adjudicated physician review;
disagreements were adjudicated by the ARIC Mortality and
Morbidity Classiﬁcation Committee using standardized ARIC
criteria.12,13
CHD was deﬁned as conﬁrmed CHD death and deﬁnite or
probably fatal and nonfatal myocardial infarction. CHD events
were identiﬁed using symptoms, ECG tracing, and serum
cardiac biomarkers. Methods for the adjudication of CHD
events by a physician panel in the ARIC have been described
in detail elsewhere.13
Ischemic stroke was identiﬁed and classiﬁed as thrombotic
or cardioembolic stroke based on discharge codes, signs,
symptoms, neuroimaging (computerized tomography/magnetic resonance imaging), and other diagnostic reports.14 All
events between study enrollment and end of year 2013 were
included in the analysis.

Statistical Analysis
CHD and ischemic stroke were analyzed separately. In the
primary analysis, prevalence of infection in the 14, 30, 42,
and 90 days before each event was compared with the
corresponding time periods exactly 1 and 2 years before the
event. A washout period of 2 days between the CVD
admission date and preceding infection date was used to
exclude infections that may have been diagnosed secondarily
at a CVD hospitalization. In addition to the overlapping
exposure periods outlined above, we also performed a
sensitivity analysis using nonoverlapping time intervals
assessing the prevalence of infection 3 to 14, 15 to 30, 31
Journal of the American Heart Association
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occurred before 1993 to ensure that Centers for Medicare
and Medicaid Services data were available for both case and
control periods.
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Results
Among the 15 792 ARIC study participants, 2356 (14.9%)
experienced an incident CHD event. Those who were aged
<67 years at the time of their event (n=1017) and those
events that occurred before 1993 (n=27) were excluded to
ensure that Centers for Medicare and Medicaid Services data
were available for both case and control periods. Our ﬁnal
sample size was n=1312 CHD cases.
A combined 1150 (7.3%) ARIC participants experienced an
incident ischemic stroke event. We excluded those who were
aged <67 years at the time of their event (n=410) and those
events that occurred before 1993 (n=13) to ensure that CMS
data were available for both case and control periods. Our
ﬁnal sample size was n=727 ischemic stroke cases. There
were 144 ARIC participants who experienced an incident CHD
and incident ischemic stroke event and were included in both
analyses.
At-event characteristics of ARIC participants who developed CHD and ischemic stroke are provided in Table 2. Mean
DOI: 10.1161/JAHA.118.009683

Table 2. At-Event Characteristics of Participants of the ARIC
Cohort Who Developed Cardiovascular Disease, 1987–2013
Characteristic

CHD (n=1312)

Ischemic Stroke (n=727)

Age, y, meanSD

75.0 (5.3)

75.1 (5.1)

Male

753 (57.4)

334 (45.9)

Female

559 (42.6)

393 (54.1)

White

949 (72.3)

492 (67.7)

Black

359 (27.4)

234 (32.2)

Other

4 (0.3)

1 (0.1)

Sex, count (%)

Race, count (%)

ARIC indicates Atherosclerosis Risk in Communities; CHD, coronary heart disease.

age at CVD event was 75 years. CHD was more common
among men (57.4%) whereas ischemic stroke (54.1%) was
more common among women. The majority of events
occurred in white participants consistent with baseline
enrollment.

Coronary Heart Disease
Of the 1312 CHD cases, 119 (9.1%) had an inpatient infection
and 366 (27.9%) had an outpatient infection in the 90 days
preceding their CHD event. The most common infections
preceding CHD events were urinary tract infections (29%),
pneumonia/respiratory infections (27%), skin and subcutaneous infections (11%), and blood infections (8%).
Table 3 contains the conditional logistic regression model
results for CHD. Both in- and outpatient infection were more
common in all case periods compared with equivalent control
periods. Inpatient infection was more common in all case
periods compared with equivalent control periods: 14-day
OR=12.83 (5.74, 28.68); 30-day OR=8.39 (4.92, 14.31); 42day OR 6.24 (4.02, 9.67); and 90-day OR, 4.48 (3.18, 6.33).
Outpatient infection was also more common in all case
periods compared with control periods: 14-day OR=3.29
(2.50, 4.32); 30-day OR=2.69 (2.14, 3.37); 42-day OR 2.45
(1.97, 3.05); and 90-day OR, 1.99 (1.64, 2.42). Inpatient
infection was a stronger CHD trigger compared with outpatient infection for all time periods (P<0.05). For both in- and
outpatient infections, controlling for the number of hospitalizations in the 9-month period preceding each exposure
period slightly attenuated the association between infection
and CHD whereas the association was strongest in exposure
periods closest to the CHD event and decreased as the time
window before CHD increased. For CHD, no signiﬁcant
interactions between in- or outpatient infection and race,
sex, or diabetes mellitus status were observed (data not
shown). Infection was generally a stronger CHD trigger among
nondiabetics, but the results were not statistically signiﬁcant.
Journal of the American Heart Association
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to 42, and 43 to 90 days before each event. We also
performed a sensitivity analysis only using 1 control period
1 year before the event. Conditional logistic regression was
used to estimate odds ratios (OR) of CVD events and 95%
conﬁdence intervals for each time period. Separate models
were run using inpatient infections and outpatient infections
to see whether the magnitude of the association differed
between infection types. Differences between ORs for in- and
outpatient infections for each outcome and time period were
compared using multinomial logistic regression. Interactions
between both in- and outpatient infection and race, sex, and
diabetes mellitus status at most recent study visit were
tested by adding interaction terms to the conditional logistic
regression models.
Potential confounders that are stable within an individual
are controlled in the case-crossover study design by having
cases serve as their own controls. Confounding by overall
health status related to age is possible because deteriorating
health could be a common cause of both infection and CVD.
As participants age and their health status decreases, their
CVD risk and risk of infection may increase, suggesting
potential positive confounding by health status.
To reduce potential confounding, only time periods proximal to the CVD event (1 and 2 years before) were included.
We further controlled for the total number of hospitalizations
for any cause in the 9 months preceding the start of each of
the 3 exposure periods (case period and 2 control periods) to
account for potential decline in overall health status. Finally,
we performed a sensitivity analysis using only 1 control period
1 year before the CVD event to further reduce potential
confounding related to overall health.

Inpatient and Outpatient Infection and CVD
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Table 3. Association Between Infection and Coronary Heart Disease in the ARIC Cohort, Odds Ratios and 95% Conﬁdence
Intervals
Case (n)

Control (n)

Crude Model

Model 1

Inpatient infections
14 d
No infection

1265

2617

Ref

Ref

Infection

47

7

13.43 (6.07, 29.71)

12.83 (5.74, 28.68)

30 d
No infection

1237

2605

Ref

Ref

Infection

75

19

8.66 (5.11, 14.67)

8.39 (4.92, 14.31)

42 d
No infection

1224

2593

Ref

Ref

Infection

88

31

6.31 (4.10, 9.73)

6.24 (4.02, 9.67)

No infection

1193

2558

Ref

Ref

Infection

119

66

4.52 (3.21, 6.36)

4.48 (3.18, 6.33)

90 d

Outpatient infections
14 d
No infection

1159

2517

Ref

Ref

Infection

153

107

3.35 (2.55, 4.50)

3.29 (2.50, 4.32)

30 d

Downloaded from http://ahajournals.org by on May 28, 2021

No infection

1084

2404

Ref

Ref

Infection

228

220

2.72 (2.17, 3.41)

2.69 (2.14, 3.37)

No infection

1052

2333

Ref

Ref

Infection

260

291

2.47 (1.99, 3.06)

2.45 (1.97, 3.05)

No infection

946

2109

Ref

Ref

Infection

366

515

2.02 (1.67, 2.46)

1.99 (1.64, 2.42)

42 d

90 d

Model 1: adjusted for total hospitalizations in the 9 months preceding each exposure period. ARIC indicates Atherosclerosis Risk in Communities.

Results from the sensitivity analysis in which only 1 control
period was used were slightly attenuated, but did not differ
substantially from the primary analysis, and are presented in
Table S2. The results of the sensitivity analysis in which
nonoverlapping time periods were used are presented in
Table S3. Similar to the main analysis, inpatient infection was
generally a stronger CHD trigger compared with outpatient
infection and CHD risk was mostly highest immediately
following an infection, although few infections made for
imprecise estimates. Results from the sensitivity analysis in
which only primarily diagnosed infections were included in our
exposure of interest did not differ from the main analysis and
are presented in Table S4. Table S5 contains the results of the
sensitivity analysis in which the exposure of interest was
limited to urinary tract infections, pneumonia, cellulitis, and

DOI: 10.1161/JAHA.118.009683

blood infections. The results of this sensitivity analysis were
also similar to the main analysis.

Stroke
Of the 727 ischemic stroke cases, 44 (6.1%) had an inpatient
infection and 173 (23.8%) had an outpatient infection in the
90 days preceding the stroke event. The most common
infections preceding stroke events were urinary tract infections (31%), pneumonia/respiratory infections (15%), skin
and subcutaneous infections (6%), and blood infections (3%).
Table 4 below contains the conditional logistic regression
model results for infection and ischemic stroke. Inpatient
infections were more common in all case periods compared
with equivalent control periods: 14-day OR=5.96 (1.93,

Journal of the American Heart Association
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Table 4. Association Between Infection and Ischemic Stroke in the ARIC Cohort, Odds Ratios and 95% Conﬁdence Intervals
Case (n)

Control (n)

Crude Model

Model 1

No infection

714

1450

Ref

Ref

Infection

13

4

6.50 (2.12, 19.34)

5.96 (1.93, 18.34)

No infection

704

1440

Ref

Ref

Infection

23

14

3.29 (1.69, 6.39)

3.06 (1.56, 6.00)

No infection

698

1436

Ref

Ref

Infection

29

18

3.46 (1.87, 6.39)

3.23 (1.74, 6.00)

683

1419

Ref

Ref

44

35

2.98 (1.82, 4.89)

2.80 (1.71, 4.61)

No infection

659

1393

Ref

Ref

Infection

68

61

2.48 (1.71, 3.60)

2.42 (1.66, 3.53)

No infection

634

1334

Ref

Ref

Infection

93

120

1.77 (1.29, 2.41)

1.69 (1.23, 2.31)

No infection

614

1302

Ref

Ref

Infection

113

152

1.75 (1.31, 2.35)

1.68 (1.25, 2.26)

No infection

554

1203

Ref

Ref

Infection

173

251

1.74 (1.34, 2.26)

1.69 (1.30, 2.20)

Inpatient infections
14 d

30 d

42 d

90 d
No infection
Infection
Outpatient infections
14 d

30 d

42 d
Downloaded from http://ahajournals.org by on May 28, 2021

90 d

Model 1: adjusted for total hospitalizations in the 9 months preceding each exposure period. ARIC indicates Atherosclerosis Risk in Communities.

18.34); 30-day OR=3.06 (1.56, 6.00); 42-day OR=3.23 (1.74,
6.00); and 90-day OR=2.80 (1.71, 4.61). Similarly, outpatient
infection was more common in all case periods compared
with control periods: 14-day OR=2.42 (1.66, 3.53); 30-day
OR=1.69 (1.23, 2.31); 42-day OR=1.68 (1.25, 2.26); and 90day OR=1.69 (1.30, 2.20). Inpatient infection was a stronger
stroke trigger compared with outpatient infection, with the
difference being of borderline statistical signiﬁcance (P<0.10)
for the 42- and 90-day time periods. For both in- and
outpatient infections, controlling for the number of hospitalizations in the 9-month period preceding each exposure
period slightly attenuated the association between infection
and ischemic stroke. The association between infection and
stroke was generally stronger in the exposure periods closest
to the stroke event and decreased as the time window before
ischemic stroke increased. For stroke, no signiﬁcant

DOI: 10.1161/JAHA.118.009683

interactions between in- or outpatient infection and race,
sex, or diabetes mellitus status were observed (data not
shown). Results from the sensitivity analysis in which only 1
control period was used did not differ substantially from the
primary analysis and are presented in Table S2. Table S3
contains the results of the sensitivity analysis in which
nonoverlapping time periods were used. Like results from the
primary analysis, inpatient infection was generally a stronger
stroke trigger compared with outpatient infection and stroke
risk was mostly highest immediately following an infection,
although the estimates are imprecise. Similarly the sensitivity
analyses in which only primary diagnosis infections were
included and in which exposure infections were limited to
urinary tract infections, pneumonia, cellulitis, and blood
infections did not differ from the main analysis and are
presented in Tables S4 and S5.

Journal of the American Heart Association
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Figure 2. Associations between inpatient and outpatient infection and coronary heart disease and
ischemic stroke in the ARIC (Atherosclerosis Risk in Communities) Cohort. *P<0.05; †P<0.10. CHD
indicates coronary heart disease; CI, conﬁdence interval; OR, odds ratio.

Downloaded from http://ahajournals.org by on May 28, 2021

In- and outpatient results for both CHD and ischemic
stroke are presented side by side in Figure 2.
Whereas outpatient infections were more common,
inpatient infections were generally stronger CVD triggers
compared with outpatient infections. It is worth considering
the attributable risk percent (AR%) of out- and inpatient
infections for both CHD and stroke. Using the approach
used by Vlak et al,15 AR%=[(OR 1/OR)9100]. The 90-day
AR of CHD for outpatient infections is 50% whereas the AR
for inpatient infection is 78%. Similarly, the 90-day AR of
stroke for outpatient infections is 41% whereas the AR for
inpatient infection is 64%. Among those with an infection,
between 41% and 78% of their CVD risk is attributable to
their infection.

Discussion
This case-crossover study nested within a population-based
cohort demonstrated that CHD and ischemic stroke risk is
higher after both in- and outpatient infection. Patients with
infection had higher odds of CHD and ischemic stroke up to
90 days after infections compared with equivalent control
periods 1 and 2 years before the event. This provides
evidence in support of our hypothesis that infection is
associated with higher acute CVD risk and that infection is a
CVD trigger. Inpatient infection was consistently a stronger
CHD and ischemic stroke trigger compared with outpatient
infection whereas the association between infection and CVD
DOI: 10.1161/JAHA.118.009683

was weaker when only considering outpatient infections, as
we hypothesized. Inpatient infections may be more severe and
trigger a stronger inﬂammatory response that results in higher
CVD risk. It is also possible that inpatient infections may be
stronger CVD triggers as a result of the “hospitalization
effect” or changes in health resulting from hospitalization
itself, including immobilization or change in medications as a
result of being hospitalized that may increase CVD risk. The
association between infection and CVD was also graded such
that the infection-CVD association was highest in the
exposure periods most proximal to the event and generally
decreased as the time window before the event increased.
Our ﬁndings corroborate previous work that has identiﬁed
a triggering association between infection and CVD and that
the risk varies by time after infection. Considering infection as
a trigger of CHD, our results are similar to those found by
Warren-Gash et al (incidence ratio=4.19),4 Corrales-Medina
et al (hazard ratio=4.07),7 Chew et al (OR=7.5),16 Kwong
et al (incidence ratio=6.05),8 and Dalager-Pedersen et al
using hospital controls (relative risk=2.32), but slightly
smaller than their analysis using population controls (30-day
relative risk=17.70).3
Our reported associations between infection and ischemic
stroke are similar in magnitude compared with those shown
by Elkind et al (OR=7.3)10 and Fullerton et al (OR=6.3).17
Notably, our group has previously published on the association between inpatient infections and ischemic stroke, also
using ARIC data.9
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preceding each exposure period. We also performed a
sensitivity analysis in which only 1 control period 1 year
before the CVD event was used to further verify that
confounding by age was absent. Other confounders that
may vary between the exposure and control periods were not
included. Analyses to assess whether the infection-CVD
relationship differed by diabetes mellitus status used diabetes
mellitus status measured at the most recent study visit,
which may not accurately reﬂect a person’s diabetes mellitus
status at the time of their CVD event. Because we used the
hospital admission date as the CVD event date, dates for
patients who do not seek immediate medical attention may
be inaccurate, but we think that this is rare because most
patients immediately seek care. We may be underascertaining
infections, especially minor ones that did not require care,
given that exposure data were collected using hospital and
Medicare claims data. This would most likely lead to
nondifferential misclassiﬁcation of the exposure that would
typically bias ORs toward the null.

Conclusion
CVD patients had higher odds of infection within 90 days
preceding their CVD event compared with equivalent control
periods 1 and 2 years previous. Although the risk of CHD and
stroke is higher following an inpatient infection, the higher
prevalence of outpatient infections suggests that the proportion of events attributable to each infection type is more
similar. Consideration should thus be given to CVD prevention
following all infections.
Previous research on CVD triggers has referred to the time
period immediately following an infection as a “treatable
moment” that may hold an opportunity for CVD prevention.10
Given that inpatient infections appear to be stronger CVD
triggers compared with outpatient infections, patients with an
inpatient infection may be of particular interest for CVD
prophylaxis. There may be a role for infection in CVD
prevention decision making, though clinical trials and a
cost-beneﬁt analysis should be considered.
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Previous investigators have suggested possible mechanisms by which infection may trigger CVD events. The
primary mechanism linking infection and CVD is through
systemic inﬂammation, which acutely leads to platelet
aggregation and hypercoagulability and chronically leads to
atherosclerotic development.18 Corrales-Medina et al posited
mechanisms by which infection may trigger coronary events,
including by inﬂammation, prothrombosis, increased biomechanical stress on coronary arteries, variations in the
coronary arterial tone, disturbed hemodynamic homoeostasis, and altered myocardial metabolic balance.19 Epaulard
et al summarized existing studies that showed that the
inﬂammatory response to infection and the coagulation and
ﬁbrinolysis processes likely share common pathways, explaining why infection is associated with thrombosis and CVD.20
Considering stroke, speciﬁcally, Elkind et al suggest that
infection may trigger stroke events through hypercoagulability, platelet activation, and impaired endothelial function.10
They further hypothesize that infection may contribute to
dehydration and immobility, which may contribute to CVD
risk. Finally, infection-induced fever and activation of the
sympathetic nervous system leading to tachycardia may
increase CVD risk.21
Our study has several clinical implications. Infection
information, particularly inpatient infections, should be
considered in assessing CVD risk. Identiﬁcation of infection
as a CVD trigger may prompt more-aggressive treatment
with standard preventive strategies, including antiplatelet
agents and statins, during and immediately after infection
to reduce the increased CVD. This time period immediately
after infection has been referred to as a treatable
moment.10 Patients suffering from an inpatient infection
may be particularly good candidates for CVD preventive
therapies. Evidence-based vaccinations may be considered
because of their ability to not only reduce infection, but
also CVD.22
Our study has a number of strengths, including a large
sample size from a community cohort, ascertainment of both
in- and outpatient infection exposure data, a rigorous
methodology to adjudicate CVD events, and a crossover
design to control for potential confounding. It also has
limitations. Like all case-crossover studies, our study may
suffer from survival bias given that we did not consider
infections in participants who did not have a CVD event. Our
study only considered the relationship between infection and
CVD among those who survived any infections and later had a
CVD event. Confounding by age is possible because as
participants age their risk of both CVD and infection increase.
However, to reduce potential confounding by age, only
control periods 1 and 2 years preceding CVD events were
examined. We also adjusted for possible confounding by the
total number of hospitalizations in the 9-month period
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Table S1. Infection type and corresponding ICD-9 codes included in the infection exposure
of interest of the sensitivity analysis.
Infection
Pneumonia
Urinary Tract Infections
Bloodstream Infections
Cellulitis

ICD-9 Codes
480*-486*
590*, 595.0, 595.1, 595.2, 595.3, 595.4, 597*, 598.0*,
599.0, 601*, 604*, 607.1, 607.2, 608.0, 608.4
038*, 790.7
681*, 682*
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Table S2. Association between infection and cardiovascular disease in the Atherosclerosis
Risk in Communities Cohort using only 1 annual crossover control period, odds ratios*
and 95% confidence intervals.
CHD
Inpatient Infection
Outpatient Infection
Stroke
Inpatient Infection
Outpatient Infection

14-Days

30 Days

42 Days

90 Days

14-Days

30 Days

42 Days

90 Days

8.73 (3.46, 22.03)
3.14 (2.23, 4.43)

5.84 (3.17, 10.78)
2.58 (1.96, 3.40)

4.62 (2.77, 7.69)
2.27 (1.75, 2.93)

3.11 (2.12, 4.56)
1.85 (1.47, 2.33)

3.98 (1.13, 14.02) 2.41 (1.11, 5.24)
2.83 (1.32, 6.04)
2.64 (1.43, 4.88)
3.61 (2.12, 6.13)
2.04 (1.37, 3.02)
1.88 (1.30, 2.74)
1.72 (1.25, 2.37)
*Adjusted for total hospitalizations in the 9 months preceding each exposure period
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Table S3. Association between infection and cardiovascular disease in the Atherosclerosis
Risk in Communities Cohort by time since the infection, odds ratios* and 95% confidence
intervals.
CHD
Inpatient Infection
Outpatient Infection
Stroke
Inpatient Infection
Outpatient Infection

3-14 Days
12.83 (5.74, 28.68)
3.29 (2.50, 4.32)
3-14 Days
5.96 (1.93, 18.34)
2.42 (1.66, 3.53)

15-30 Days
4.75 (2.39, 9.45)
1.40 (1.02,1.93)
15-30 Days
1.86 (0.76, 4.55)
0.77 (0.47, 1.27)

31-42 Days
2.54 (1.09, 5.94)
0.94 (0.61, 1.44)
31-42 Days
2.76 (0.78, 9.83)
1.26 (0.70, 2.25)

*Adjusted for total hospitalizations in the 9 months preceding each exposure period

43-90 Days
1.89 (1.14, 3.11)
0.91 (0.71, 1.18)
43-90 Days
1.85 (0.88, 3.90)
1.28 (0.89, 1.82)
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Table S4. Association between primary diagnosis infection and cardiovascular disease in
the Atherosclerosis Risk in Communities Cohort, odds ratios* and 95% confidence
intervals.
CHD
Inpatient Infection
Outpatient Infection
Stroke
Inpatient Infection
Outpatient Infection

14-Days
5.42 (2.05, 14.30)
2.75 (1.99, 3.79)
14-Days
N/A
3.02 (0.98, 9.31)

30 Days
3.93 (1.94, 7.96)
2.44 (1.88, 3.16)
30 Days
3.49 (0.64, 19.09)
1.89 (0.79, 4.47)

42 Days
3.02 (1.65, 5.50)
2.03 (1.59, 2.59)
42 Days
5.22 (1.05, 25.92)
2.41 (1.12, 5.22)

*Adjusted for total hospitalizations in the 9 months preceding each exposure period

90 Days
2.18 (1.38, 3.44)
1.78 (1.45, 2.19)
90 Days
3.11 (1.12, 8.60)
1.69 (0.93, 3.06)
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Table S5. Association between urinary tract infections, pneumonia, cellulitis, and blood
infections and cardiovascular disease in the Atherosclerosis Risk in Communities Cohort,
odds ratios* and 95% confidence intervals.
CHD
Inpatient Infection
Outpatient Infection
Stroke
Inpatient Infection
Outpatient Infection

14-Days
14.56 (5.64, 37.60)
5.45 (3.47, 8.55)
14-Days
19.62 (2.51, 153.47)
2.72 (1.58, 4.67)

30 Days
9.64 (5.14, 18.08)
3.41 (2.48, 4.70)
30 Days
5.67 (2.04, 15.78)
1.80 (1.14, 2.83)

42 Days
7.23 (4.32, 12.11)
3.22 (2.39, 4.33)
42 Days
6.61 (2.65, 16.49)
1.71 (1.14, 2.58)

*Adjusted for total hospitalizations in the 9 months preceding each exposure period

90 Days
447 (3.04, 6.56)
2.54 (1.98, 3.26)
90 Days
2.75 (1.53, 4.95)
1.46 (1.04, 2.04)
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